Clinical Trial Update: Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing inhaled pentamidine plus oral miltefosine for mucosal leishmaniasis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Leishmaniasis

Drugs mentioned

• miltefosine (oral) (miltefosine)
• pentamidine (inhaled) (pentamidine)

Snippet

Sponsor: Fundacion Nacional de Dermatologia | Conditions: Mucosal Leishmaniasis | Phase 2 | Status: RECRUITING